88 results
SC TO-T
EX-99
BMY
Bristol-Myers Squibb Co.
25 Jan 24
Third party tender offer statement
8:13am
) certain anti-corruption and anti-money laundering matters; (t) regulatory matters; and (u) financial advisors.
In the Merger Agreement, Purchaser
8-K
EX-10.5
BMY
Bristol-Myers Squibb Co.
4 May 21
Departure of Directors or Certain Officers
4:16pm
of consent, you understand that you may contact the International Compensation and Benefits Group.
Anti-Corruption Information. Anti-corruption laws prohibit
8-K
EX-10.2
0nzcykn
4 May 21
Departure of Directors or Certain Officers
4:16pm
8-K
EX-10.4
0eppida1jbnc3x8
4 May 21
Departure of Directors or Certain Officers
4:16pm
8-K
EX-10.3
gh65l 8w7z9kp100ay4
4 May 21
Departure of Directors or Certain Officers
4:16pm
8-K
EX-10.1
zs9h4t
4 May 21
Departure of Directors or Certain Officers
4:16pm
8-K
EX-10.1
k49d9
6 Nov 20
Entry into a Material Definitive Agreement
8:00am
8-K
vr951donv fo
6 Nov 20
Entry into a Material Definitive Agreement
8:00am
SC TO-T
EX-99
7e7vtyo to2nu
19 Oct 20
Third party tender offer statement
6:03am